Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors

被引:26
作者
Butini, Stefania [1 ,2 ]
Campiani, Giuseppe [1 ,2 ]
Franceschini, Silvia [1 ,2 ]
Trotta, Francesco [1 ,2 ]
Kumar, Vinod [1 ,2 ]
Guarino, Egeria [1 ,2 ]
Borrelli, Giuseppe [1 ,2 ]
Fiorini, Isabella [1 ,2 ]
Novellino, Ettore [1 ,3 ,4 ]
Fattorusso, Caterina [1 ,3 ,4 ]
Persico, Marco [1 ,3 ,4 ]
Orteca, Nausicaa [1 ,3 ,4 ]
Sandager-Nielsen, Karin [5 ]
Jacobsen, Thomas Amos [5 ]
Madsen, Kim [5 ]
Scheel-Kruger, Jorgen [5 ]
Gemma, Sandra [1 ,2 ]
机构
[1] Univ Siena, European Res Ctr Drug Discovery & Dev, I-53100 Siena, Italy
[2] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[3] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, I-80131 Naples, Italy
[4] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
[5] NeuroSearch AS, DK-2750 Ballerup, Denmark
关键词
ATYPICAL ANTIPSYCHOTIC AGENTS; DESIGN;
D O I
10.1021/jm100294b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a continuation of our efforts to develop innovative ligands for D-3, 5-HT1A, and 5-HT2A receptors with low propensity to block hERG channels, we propose a series bishetero(homo)arylpiperazines 5a-m as novel and potent multifunctional ligands characterized by low occupancy at D-2 and 5-HT2C receptors.
引用
收藏
页码:4803 / 4807
页数:5
相关论文
共 16 条
[1]   Aripiprazole: Efficacy and tolerability profile of a novel-acting atypical antipsychotic [J].
Buckley, PF .
DRUGS OF TODAY, 2003, 39 (02) :145-151
[2]  
Butini S, 2003, EXPERT OPIN THER PAT, V13, P425, DOI 10.1517/13543776.13.4.425
[3]   Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors: Design, Synthesis, and Effects on Behavior [J].
Butini, Stefania ;
Gemma, Sandra ;
Campiani, Giuseppe ;
Franceschini, Silvia ;
Trotta, Francesco ;
Borriello, Marianna ;
Ceres, Nicoletta ;
Ros, Sindu ;
Coccone, Salvatore Sanna ;
Bernetti, Matteo ;
De Angelis, Meri ;
Brindisi, Margherita ;
Nacci, Vito ;
Fiorini, Isabella ;
Novellino, Ettore ;
Cagnotto, Alfredo ;
Mennini, Tiziana ;
Sandager-Nielsen, Karin ;
Andreasen, Jesper Tobias ;
Scheel-Kruger, Jorgen ;
Mikkelsen, Jens D. ;
Fattorusso, Caterina .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (01) :151-169
[4]   Novel atypical antipsychotic agents: Rational design, an efficient palladium-catalyzed route, and pharmacological studies [J].
Campiani, G ;
Butini, S ;
Fattorusso, C ;
Trotta, F ;
Gemma, S ;
Catalanotti, B ;
Nacci, V ;
Fiorini, I ;
Cagnotto, A ;
Mereghetti, I ;
Mennini, T ;
Minetti, P ;
Di Cesare, MA ;
Stasi, MA ;
Di Serio, S ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1705-1708
[5]   Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents [J].
Campiani, G ;
Butini, S ;
Fattorusso, C ;
Catalanotti, B ;
Gemma, S ;
Nacci, V ;
Morelli, E ;
Cagnotto, A ;
Mereghetti, I ;
Mennini, T ;
Carli, M ;
Minetti, P ;
Di Cesare, MA ;
Mastroianni, D ;
Scafetta, N ;
Galletti, B ;
Stasi, MA ;
Castorina, M ;
Pacifici, L ;
Vertechy, M ;
Di Serio, S ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) :143-157
[6]   Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands:: Inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors [J].
Campiani, G ;
Butini, S ;
Trotta, F ;
Fattorusso, C ;
Catalanotti, B ;
Aiello, F ;
Gemma, S ;
Nacci, V ;
Novellino, E ;
Stark, JA ;
Cagnotto, A ;
Fumagalli, E ;
Carnovali, F ;
Cervo, L ;
Mennini, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) :3822-3839
[7]   Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies [J].
Campiani, G ;
Butini, S ;
Gemma, S ;
Nacci, V ;
Fattorusso, C ;
Catalanotti, B ;
Giorgi, G ;
Cagnotto, A ;
Goegan, M ;
Mennini, T ;
Minetti, P ;
Di Cesare, MA ;
Mastroianni, D ;
Scafetta, N ;
Galletti, B ;
Stasi, MA ;
Castorina, M ;
Pacifici, L ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :344-359
[8]   New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure [J].
Campiani, G ;
Nacci, V ;
Bechelli, S ;
Ciani, SM ;
Garofalo, A ;
Fiorini, I ;
Wikström, H ;
de Boer, P ;
Liao, Y ;
Tepper, PG ;
Cagnotto, A ;
Mennini, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) :3763-3772
[9]   Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].
Geddes, J ;
Freemantle, N ;
Harrison, P ;
Bebbington, P .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376
[10]   Olanzapine-associated diabetes mellitus [J].
Koller, EA ;
Doraiswamy, PN .
PHARMACOTHERAPY, 2002, 22 (07) :841-852